Method for inhibiting scale formation and/or dispersing iron in reverse osmosis systems

Abstract: A method for inhibiting calcium sulfate scale formation and deposition and/or dispersing iron from a feedstream passing through a reverse osmosis system which comprises the steps of: controlling the pH of the feedstream within the range between about 6.0 to about 7.0; controlling the temperature of the feedstream within the range between about 50 to about 80°F; and adding a scale inhibitor and/or iron dispersant to the feedstream in an amount between about 0.002 ppm per ppm hardness (as CaCO₃) of the feedstream to about 0.005 ppm per ppm hardness (as CaCO₃) of the feedstream, the scale inhibitor and/or iron dispersant comprising a water-soluble organic phosphonate, an N-substituted acrylamide polymer, caustic and water.

Description: A method for inhibiting calcium sulfate scale formation and deposition and/or dispersing iron from a feedstream passing through a reverse osmosis system which comprises the steps of: controlling the pH of the feedstream; controlling the temperature of the feedstream; and adding a scale inhibitor and/or iron dispersant which comprises an acrylic acid/acrylamide/acrylamidomethylsulphonic acid terpolymer, a phosphonate, caustic and water to the feedstream. BACKGROUND OF THE INVENTION Purification of water by reverse osmosis (RO) is growing in popularity. Specifically, it is used for seawater desalination, potable water production, cooling tower make-up, process water generation, boiler feedwater pretreatment and the like. It offers the advantages of removing both organic and inorganic contaminants to yield water which is up to 98% pure. If ion exchange polishing is used downstream of the RO unit, it also saves money by reducing the frequency of demineralizer regenerations and their associated waste disposal costs. The RO process consists of using pressure to drive water through a semipermeable membrane. As the pure water (permeate) passes through the salt rejecting layer of the membrane, the remaining water (retentate) is enriched in contaminants. A turbulence promoter, present within the membrane module, helps prevent the formation of large concentration gradients within the unit. Nevertheless, next to the barrier layer, an area of concentration polarization develops, and the concentrations of common scale forming salts such as CaCO 3 and CaSO 4 often exceed their solubility limits and precipitate on the surface. In addition, the presence of insoluble iron fines may also foul the membrane surface. Such scaling and fouling decreases the production of pure water. To regain the product water flow, higher driving pressures are necessary, which result in increased energy costs and potential damage to the membranes. A significant operating cost factor of a reverse osmosis system is the cost of the membranes themselves. With proper care membranes can last for years before replacement becomes necessary. If the membranes experience fouling by deposits of material on their surface, this may result in increased energy consumption, or membrane failure which would ultimately cause an unscheduled shutdown and significant replacement costs. Most RO systems incorporate some type of pretreatment system consisting of filters to remove suspended matter which minimizes fouling. Also, chemical addition is often required to inhibit scaling. Foulants are softer, non-crystalline deposits, which adhere to the membrane surface and include: colloids, small particles, oil, biological growth, metal oxides, and silica. Mineral scales are hard, dense crystalline precipitates which include, but are not limited to, CaCO 3 , CaSO 4 , BaSO 4 , SrSO 4 , CaF 2 , and Mg(OH) 2 . RO end users frequently employ chemical pretreatments such as the addition of polymeric scale inhibitors/dispersants to inhibit undesirable mineral scaling. In some cases, inorganic inhibitors such as sodium hexametaphosphate (SHMP) are used. There are many types of scale inhibitors which have been used. For example U.S. Patent No. 4,563,284 (Amjad), issued January 7, 1986, discloses a method for inhibiting formation and deposition of scale-forming salts by adding thereto an effective threshold amount of a phosphonocarboxylic acid and a telomeric phosphinocarboxylic acid that contains features of both phosphonates and polyacrylates. U.S. Patent No. 4,762,621 (Masler, III et al.), issued August 9, 1988, discloses a scale inhibitor comprising a copolymer of an acrylic acid and a lower alkyl ester of itaconic acid. U.S. Patent No. 4,784,774 (Amjad et al.), issued November 15, 1988, discloses a scale inhibitor containing a homopolymer of maleic acid or a copolymer of a monounsaturated monocarboxylic or dicarboxylic acid or salt thereof containing 3 to 5 carbon atoms and a phosphonoalkane carboxylic acid. U.S. Patent No. 4,952,327 (Amjad et al.), issued August 28, 1990, discloses a scale inhibitor obtained by adding to an aqueous medium 0.5 to 500 ppm of a copolymer containing at least one of each of the following three monomers: (a) monounsaturated carboxylic acids as well as salts and anhydrides thereof such as acrylic acid, methacrylic acid, or maleic acid; (b) acrylamidoalkane sulfonic acids and salts thereof, such as 2-acrylamido-2-methylpropane sulfonic acid (AMPS®, a registered trademark of the Lubrizol Corporation); and (c) styrene sulfonic acid and its salts. U.S. Patent No. 4,652,377 (Amjad), issued March 24, 1987, discloses a scale inhibitor comprised of a polyacrylic acid, phytic acid, and a phosphonocarboxylic acid containing at least one phosphono group, at least two carboxylic groups, and a hydrocarbon chain of at least two carbon atoms. U.S. Patent No. 5,000,856 (Chen et al.), issued March 19,1991,discloses a scale inhibitor which comprises (a) a maleic acid/allyl sulfonic acid copolymer, (b) an acrylic acid/acrylamidomethylpropyl sulfonic acid polymer, and a phosphonate such as hexamethylenediamine tetraphosphonic acid or 2-phosphonobutane-1,2,4-tricarboxylic acid, ammonium salt. The present invention is directed to the use of a terpolymer of acrylic acid/acrylamide/sulfonated acrylamide in conjunction with a phosphonated product as scale inhibitor/iron dispersant in reverse osmosis systems. This novel antiscalant/dispersant has proven particularly effective in inhibiting CaSO 4 scale on RO membranes, as well as in dispersing Of iron. The present inventors have developed a suitable dosage profile which demonstrated effective minimum dosages of this antiscalant/dispersant when used in RO systems. Also, the pH and temperature of the RO feedstream must be controlled in order to properly inhibit mineral scaling within the system. The present invention also provides many additional advantages which shall become apparent as described below. SUMMARY OF THE INVENTION A method for inhibiting calcium sulfate scale formation and deposition and/or dispersing iron from a feedstream passing through a reverse osmosis system which comprises the steps of: controlling the pH of the feedstream within the range between 6.0 to 7.0 by the use of sulfuric acid in an amount such that only CaSO 4 is precipitated, not CaCO 3 ; controlling the temperature of said feedstream within the range between 10 to 27°C (50 to 80°F); and adding a scale inhibitor to the feedstream in an amount between 0.002 ppm per ppm hardness (as CaCO 3 ) of the feedstream to 0.005 ppm per ppm hardness (as CaCO 3 ) of the feedstream. The scale inhibitor comprises a water-soluble organic phosphonate and an N-substituted acrylamide polymer containing an amide structure as follows: where R 2 is hydrogen or methyl, R 1 is a hydrogen or an alkyl, and R is alkylene or phenylene and X is sulfonate, (poly) hydroxyl, (poly) carboxyl or carbonyl, and combinations thereof, with the weight ratio of polymer to phosphonate being within the range of 0.2:1 to 6:1. In the above formula "alkyl" means a straight or branched, unsubstituted or substituted alkyl group having preferably 1 to 6 carbon atoms, especially 1 to 4 carbon atoms; and "alkylene" means a straight or branched alkylene group having preferably 1 to 12, especially 1 to 6, particularly 1 to 4 carbon atoms and being optionally substituted by preferably 1 to 6, especially 1 to 3 substitutents; and "poly" means 1 or more, preferably 1 to 3. The substituents of "alkylene" are preferably selected from the group consisting of sulfonate, hydroxyl, carboxyl and carbonyl radicals. The organic phosphonate is preferably selected from the group consisting of: 2-phosphonobutane-1,2,4-tricarboxylic acid and nitrilophosphonic acids (e.g., [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt). One preferred composition is an organic phosphonate of 2-phosphonobutane-1,2,4-tricarboxylic acid, an N-substituted acrylamide polymer, a caustic capable of neutralizing to pH of 6-7, and water. This unique polymer composition can also be used as an iron dispersant to disperse iron disposed in a feedstream passing through a reverse osmosis system. It is preferable that the active iron dispersant to iron ratio be about 0.5:1, more preferably about 0.6:1 or greater. Other and further objects, advantages and features of the present invention will be understood by reference to the following specification. BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a graph plotting % Fe dispersed verses hardness (as CaCO 3 ) of a feedstream for a constant dosage of iron (10 ppm) and a scale inhibitor (based on polymer actives) which comprises an acrylic acid/acrylamide/acrylamidomethyl-sulphonic acid terpolymer and [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt; Fig. 2 is a graph plotting % Fe dispersed verses hardness (as CaCO 3 ) of a feedstream for a constant dosage of iron (5 ppm) and a scale inhibitor (based on polymer actives) which comprises an acrylic acid/acrylamide/acrylamidomethyl-sulphonic acid terpolymer and [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt; and Fig. 3 is a contour plot showing % Fe dispersed and % CaSO 4 inhibition for various ratios of active phosphonate and polymers. DESCRIPTION OF THE PREFERRED EMBODIMENTS It has been found that post-polymerization derivatized hydrocarbon polymers can be used in conjunction with phosphonates to provide very effective scale inhibiting formulations for feedstreams processed in reverse osmosis systems to remove salts therefrom. Test results show these materials have synergistic effects which enhance the scale inhibition of each independent component. This scale inhibitor is also capable of dispersing iron contained within a feedwater (i.e., iron dispersancy or iron stabilization). A preferred scale inhibitor according to the present invention comprises a water-soluble organic phosphonate and an N-substituted acrylamide polymer containing an amide structure. The N-substituted acrylamide polymer is preferably as follows: where R 2 is hydrogen or methyl, R 1 is a hydrogen or an alkyl, and R is alkylene or phenylene and X is sulfonate, (poly) hydroxyl, (poly) carboxyl or carbonyl, and combinations thereof, with the weight ratio of polymer to phosphonate being within the range of about 0.2:1 to about 6:1. In the above formula "alkyl" means a straight or branched, unsubstituted or substituted alkyl group having preferably 1 to 6 carbon atoms, especially 1 to 4 carbon atoms; and "alkylene" means a straight or branched alkylene group having preferably 1 to 12, especially 1 to 6,particularly 1 to 4 carbon atoms and being optionally substituted by preferably 1 to 6, especially 1 to 3 substitutents; and "poly" means 1 or more, preferably 1 to 3. The substituents of "alkylene" are preferably selected from the group consisting of sulfonate, hydroxyl, carboxyl and carbonyl radicals. The term "phosphonate" refers to organic materials containing one or more -PO 3 H 2 groups and salts thereof. The term "acryl" includes the term "methacryl". One example of an N-substituted acrylamide polymer is a terpolymer of acrylic acid/acrylamide/acrylamidomethylsulfonic acid having a mole ratio of acrylic acid to acrylamide to acrylamidomethylsulphonic acid within the range between 13-95 to 0-73 to 5-41, respectively; and wherein the polymer has a weight average molecular weight within the range of 7,000 to 82,000. More preferably, the terpolymer has a mole ratio of acrylic acid to acrylamide to acrylamidomethylsulphonic acid within the range of 40-90 to 0-50 to 10-40, respectively; and wherein the polymer has a weight average molecular weight within the range of 10,000 to 40,000. The preferred organic phosphonate is selected from the group consisting: of 2-phosphonobutane-1,2,4-tricarboxylic acid and nitrilophosphonic acids. One preferred nitrilophosphonic acid is [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt. The invention is also directed to a method for dispersing and maintaining dispersed particulate or inorganic matter, particularly iron oxide and clay, in an aqueous medium containing such matter and/or for controlling the deposition of scale-imparting precipitates on surfaces of equipment used in recirculating or the once-through water systems containing such precipitates, or precipitate-forming ions, under conditions which form the precipitates. This method is particularly effective for inhibiting calcium sulfate scale formation and deposition from a feedstream passing through a reverse osmosis system disposed within a plant for use in providing boiler feedwater, cooling tower make-up water, purified process water, potable water, or for use in the desalination of seawater or the like. The reverse osmosis system is capable of purifying water from brine solutions or brackish waters containing a high concentration of salts. This method comprises the steps of: controlling the pH of the feedstream within the range between 6.0 to 7.0; controlling the temperature of the feedstream within the range between 10 to 27°C (50 to 80°F); and adding a scale inhibitor to the feedstream. The scale inhibitor is preferably added at a minimum concentration of 0.002 ppm per ppm hardness (as CaCO 3 ) to a maximum concentration of 0.005 ppm per ppm hardness (as CaCO 3 ) of the feedstream. The scale inhibitor is preferably added to the feedstream at a minimum of about 0.3 to a maximum of about 20 ppm polymer actives. It is possible that the antiscalant may be used in an amount less than 0.3 ppm polymer actives, in some cases. The pH of the feedstream is controlled by the use of sulfuric acid in an amount such that only CaSO 4 is precipitated, not CaCO 3 . The pH of the feedstream is preferably controlled within the range between about 6.0 to about 7.0, most preferably such that it does not exceed 6.5. When iron is contained within a feedstream passing through a reverse osmosis system it can be dispersed by the steps of: controlling the pH of the feedstream within the range between 6.0 to 8.5; controlling the temperature of the feedstream within the range between 10 to 27°C (30 to 80°F); and adding an iron dispersant to the feedstream. The iron dispersant to iron ratio is approximately 0.5:1 or greater ,preferably 0.6:1 or greater. THE DERIVATIZED POLYMERS The polymers of this invention have been prepared by post-polymerization derivatization. The derivatizing agents of the invention are hydrocarbon groups containing both an amino functionality and at least one of the following groups: 1. (poly)hydroxy alkyl(aryl); 2. alkyl and aryl(poly)carboxylic acids and ester analogues; 3. aminoalky(aryl) and quaternized amine analogues; 4. halogenated alkyl(aryl); 5. (poly)ether alkyl(aryl); 6. (di)alkyl; 7. alkyl phosphonic acid; 8. alkyl keto carboxylic acid; 9. hydroxyalkyl sulfonic acid; and 10. (aryl)alkyl sulfonic acid, wherein the prefix "poly" refers to two or more such functionalities. The derivatization process of the invention includes direct amidation of polyalkyl carboxylic acids and transamidation of copolymers containing carboxylic acid and (meth)acrylamide units. Particularly advantageous are polymers of the present invention containing sulfomethylamide (AMS), sulfoethylamide (AES), sulfophenylamide (APS), 2-hydroxy-3-sulfopropylamide (HAPS) and 2,3-dihydroxypropylamide units which are produced by transamidation using acrylic acid (AA) or acrylamide (Am) homopolymers and copolymers, including terpolymers, which have a mole percent of acrylamide or homologous units of a minimum of about 10%. The transamidation is achieved using such reactants as aminomethanesulfonic acid, 2-aminoethanesulfonic acid (taurine, 2-AES), 4-aminobenzenesulfonic acid (p-sulfanilic acid), 1-amino-2-hydroxy-3-propanesulfonic acid, or 2,3-dihydroxypropylamine in aqueous or like polar media at temperatures on the order of about 150°C. Once initiated, the reactions go essentially to completion. Other particularly advantageous polymeric sulfonates of the present invention are produced by an addition reaction between an aminosulfonic acid, such as sulfanilic acid, and taurine, or their sodium salts, and a copolymer of maleic anhydride and a vinylic compound such as styrene, methyl vinyl ether, or (meth)acrylamide. THE PHOSPHONATES Generally any water-soluble phosphonate may be used that is capable of providing scale inhibition in acidified systems. See U.S. Patent Nos. 4,756,881 (Hoots et al.), issued July 12, 1988, and 4,929,425 (Hoots et al.), issued May 29, 1990, which refer to a number of representative phosphonates. As such, the subject matter of U.S. Patent Nos. 4,756,881 and 4,929,425 are incorporated herein by reference. Preferred phosphonates, however, are selected from the group consisting of: 2-phosphonobutane-1,2,4-tricarboxylic acid; and nitrilophosphonic acids (e.g., [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt). Scale inhibitors can be used in applications other than purification of boiler feedwater, cooling tower make-up, process water, potable water and seawater desalination where calcium scaling is a major consideration. Particular applications contemplated herein are flash distillation, oil field applications, pulp digesters, phosphoric acid production, sugar evaporators, and the like. Scale formation occurs when the concentrations of species, such as calcium and magnesium, exceed the solubility constants of their sparingly soluble salts. The factors which affect scale formation include: temperature, pH, and competitive equilibria. In order to demonstrate the effectiveness of the scale inhibitor/dispersant polymer of the present invention versus conventional antiscalant treatment programs, the present inventors have conducted the following experiments. EXAMPLE 1 The following is an experimental design demonstrating the optimization of the scale inhibitor of the present invention. The scale inhibitor is a compound comprising a terpolymer of acrylic acid/acrylamide/acrylamido-methylsulphonic acid (50:30:20) and [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt (sold under the tradename Dequest 2054 by Monsanto). The results are set forth below in Table 1. Run No. Terpolymer (ppm active) Dequest 2054 (ppm active) Inhibition (%) Fe Dispersed (%) 1 0.57 0.22 107 1.6 2 0.00 4.0 110 98.6 3 0.00 4.00 103 1.0 4 1.14 0.00 92 4.7 5 5.00 4.00 106 93.1 6 0.19 0.90 103 0.5 7 0.00 0.45 -4 0.5 8 0.00 0.90 124 1.1 9 10.00 2.00 130 100.0 10 1.14 0.45 105 10.4 11 1.14 0.00 99 5.5 12 1.14 0.22 116 10.7 13 0.00 0.00 0 1.0 14 5.00 2.00 135 96.3 15 0.64 0.60 113 0.4 16 10.00 0.00 117 94.8 17 1.14 0.45 111 2.3 18 0.57 0.90 122 0.4 19 10.00 0.00 122 96.6 20 10.00 4.00 119 92.9 21 0.38 0.11 109 0.9 22 0.19 0.11 0 1.3 23 0.00 4.00 117 2.1 24 0.57 0.90 119 1.5 The results from Table 1 above were fitted to a predictive model using a standard experimental design software package such as RS/1 marketed by BBN Software Products. Based on this model, contour plots showing % Fe dispersion and % CaSO 4 inhibition were generated on Fig. 3. Nearly all of the combinations in table 1 dispersed CaSO 4 , but not all were capable of dispersing iron. EXAMPLE 2 A scale inhibitor/iron dispersant in accordance with the present invention, i.e., a terpolymer of acrylic acid/acrylamide/acryiamidomethylsulphonic acid (50:30:20) and [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt (sold under the tradename Dequest 2054), was tested for iron dispersancy at varying dosage and hardness levels. At 10 ppm active, 10 ppm Fe, and standard condition (560 ppm) hardness, the product achieved 100% iron dispersion. The particle size of the dispersed iron is <0.22µ. As the level of hardness was increased, the particle agglomeration increased so that at 1680 ppm hardness, only 19% Fe is <0.22µ. If the initial iron was decreased; a proportional decrease in particle size was observed. CaSO 4 scale was not observed under the conditions of this test. EXAMPLE 3 Iron dispersion experiments were run using a scale inhibitor which comprises a terpolymer of acrylic acid/acrylamide/acrylamidomethylsulphonic acid (50:30:20) and [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt (sold under the tradename Dequest 2054 by Monsanto). It was the purpose of these experiments to examine the dosage and effect of hardness and iron form on dispersion ability. An iron hydroxide test set forth below in Table 2 was conducted at a pH of 8.5, 300 ppm Ca (as CaCO 3 ), 260 ppm Mg (as CaCO 3 ), 10 ppm Fe, 10 ppm active treatment, at a temperature of 60°C for 2 hours, and then at room temperature for 24 hours. Treatment (ppm) Supernatant % Fe 0.45µm Filtrate % Fe 0.22µm Filtrate % Fe 10 100 100 100 8 101 100 87 6 104 90 42 100% iron dispersion was achieved with as low as 5 ppm product. However, particle size was increased as dosage was decreased. Figs. 1 and 2, attached hereto, examine the effect of hardness level on dispersion. From Figs. 1 and 2, although 100% dispersion was maintained, particle size increases. This makes sense in that the product has a stronger affinity for the hardness than for the iron. As the hardness increases it consumes treatment, which in turn means that less treatment is available for controlling the Fe particle size. EXAMPLE 4 A scale inhibitor/iron dispersant formulation according to the present invention was prepared from 0.38 ppm acrylic acid/acrylamide/acrylamidomethylsulphonic acid (50:30:20) and 0.15 ppm [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt. This formula consisted of an aqueous solution containing 20.2% of a 37% solution of acrylic acid/acrylamide/acrylamidomethylsulphonic acid solution (7.9% actives based on total polymer in solution), 8.34% of a 35% solution of [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt solution (3% actives based on total polymer in solution), and 1.6% of a 50% NaOH solution; the formula was at a pH of 6.5. This scale inhibitor/iron dispersant formulation achieved 100% CaSO 4 inhibition under test conditions of 2,000 ppm Ca. This formula was also tested for iron dispersancy and not only achieved 100% iron dispersed, but maintains particle size under 0.22 m at a dosage of 1 ppm actives/ppm Fe. EXAMPLE 5 A scale inhibitor/iron dispersant formulation was prepared using 27% of a 37% solution of acrylic acid/acrylamide/acrylamido-methylsulphonic acid solution (10% actives based on total polymer in solution), 5.8% of 35% solution of [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt (2% actives based on total polymer in solution), 3.2% of a NaOH solution and the remainder being water. EXAMPLE 6 The procedure used in the following demonstration was devised to examine CaSO 4 , Ca 3 (PO 4 ) 2 , and CaCO 3 scale formation. In general, solutions of an inhibitor (generally between 5-50 ppm) and anions (e.g., SO 4 -2 , PO 4 -3 , and CO 3 -2 ) were prepared and adjusted with caustic to a specific pH. These solutions were equilibrated at the specified temperature and pH for 45 minutes. After the conditioning period, the calcium solution (i.e., a solution of CaCl 2 · 2H 2 O) was added. This final solution was maintained at the specified temperature and pH for 20 hours. The pH was controlled by automatic addition of 0.1 N NaOH with a peristaltic pump controlled by a pH controller. The antiscalant screening assembly used in this experiment consisted of a temperature controlled bath equipped with a magnetic stirring device. Each of the cells in the bath was equipped with a stir bar, a NaOH feed tube, and a pH electrode interfaced to the NaOH feed via a pH controller. Each cell was covered to minimize evaporation. Samples were withdrawn at Time = 0 and 20 hours, filtered through 0.22µ filters and analyzed for calcium using standard known methods. For comparative purposes, the ability to inhibit scale formation and deposition is expressed as % Inhibition (%I) which is calculated by the following formula: % Inhibition = (Ion)exp - (Ion)Blank Final (Ion)initial - (Ion)Blank Final X 100 where, (Ion)exp is the concentration of ion in the filtrate in the presence of polymer at Time (t), (Ion)Blank Final is the concentration of ion in the filtrate of the blank at Time (t), and (Ion)initial is the initial concentration of ion at Time zero. Various tests were run to examine product effect on CaSO 4 inhibition. Sample 1 is the formulation according to one embodiment of the present invention wherein the scale inhibitor/dispersant comprises acrylic acid/acrylamide/acrylamidomethylsulphonic acid (50:30:20) and [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt. Sample 2 is 2-phosphonobutane-1,2,4-tricarboxylic acid (PBTC), alone. Sample 3 is acrylic acid/acrylamide/acrylamidomethylsulphonic acid (50:30:20), alone. Sample 4 is acrylic acid/acrylamide/acrylamidomethylsulphonic acid (50:30:20) and PBTC. Sample 5 is [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt, sold by Monsanto under the trademark Dequest 2054. Sample 6 is aminotri(methylene phosphonic acid), sold by Monsanto under the trademark Dequest 2000. The results are set forth below in Table 3. Sample No. ppm Active Phosphonate ppm Product Terpolymer %I±1% 1 0.15 0.38 100 1 0.15 0.76 101 1 0.3 0.38 99 1 0.3 0.76 101 1 0.6 0.38 101 1 0.6 0.76 104 1 0.9 0.38 102 1 0.9 0.76 104 2 0.90 0 11 2 0.90 0 10 2 1.20 0 10 3 0 1.14 11 3 0 1.14 11 3 0 1.14 10 3 0 4.00 97 3 0 10.00 95 4 0.30 0.76 10 4 0.60 0.76 12 4 0.60 0.76 105 4 0.90 0.76 98 4 1.20 0.76 98 4 0.30 1.13 93 4 0.60 1.14 99 4 0.90 1.13 96 4 0.30 1.52 15 5 0.60 0 10 5 0.90 0 101 6 0.60 0 10 6 0.90 0 17 Where the aminotri(methylene phosphonic acid) was ineffective at inhibiting CaSO 4 scale, the [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt achieves 100% inhibition. Also sample 1 which combines [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt and acrylic acid/acrylamide/acrylamidomethylsulphonic acid demonstrated excellent CaSO 4 scale inhibition with as little as 0.15 ppm phosphonate and 0.38 ppm of the terpolymer. Sample 4 which combines PBTC and acrylic acid/acrylamide/acrylamidomethylsulphonic acid also demonstrated excellent CaSO 4 scale inhibition with as little as 0.30 ppm phosphonate and 1.13 ppm of the terpolymer. A dosage of 0.9 ppm of [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid, hexapotassium salt, alone, was required to attain 100% scale inhibition. Other phosphonates such as Dequest 2000 and PBTC were unable to attain 100% scale inhibition even at dosages of 0.9 ppm. While we have shown and described several embodiments in accordance with our invention, it is to be clearly understood that the same are susceptible to numerous changes apparent to one skilled in the art. Therefore, we do not wish to be limited to the details shown and described but intend to show all changes and modifications which come within the scope of the appended claims.

Claims: A method for inhibiting calcium sulfate scale formation and deposition and/or for dispersing iron from a feedstream passing through a reverse osmosis system which comprises the steps of: a) controlling the pH of said feedstream within the range from 6.0 to 7.0 by the use of sulfuric acid in an amount such that only CaSO 4 is precipitated, not CaCO 3; b) controlling the temperature of said feedstream within the range of from 10 to 27°C (50-80°F); and c) adding a product polymer capable of both inhibiting scale formation/deposition and dispersing iron to said feedstream in an amount of from 0.002 to 0.005 ppm per ppm hardness (as CaCO 3 ) of said feedstream, said product polymer comprising a water-soluble organic phosphonate and an N-substituted acrylamide polymer containing an amide structure as follows: where R 2 is hydrogen or methyl, R 1 is hydrogen or alkyl, R is alkylene or phenylene and X is sulfonate, (poly)hydroxyl, (poly)carboxyl or carbonyl, and combinations thereof, with the weight ratio of polymer to phosphonate being within the range of from 0.2:1 to 6:1. The method according to claim 1 wherein said N-substituted acrylamide polymer is an acrylic acid/acrylamide/acrylamidomethylsulphonic acid polymer or salt thereof having a mole ratio of acrylic acid to acrylamide to acrylamidomethylsulphonic acid within the range of (13-95):(0-73):(5-41), respectively; and wherein the polymer has a weight average molecular weight within the range of from 7,000 to 82,000. The method according to claim 2 wherein said polymer has a mole ratio of acrylic acid to acrylamide to acrylamidomethylsulphonic acid within the range of (40-90):(0-50):(10-40), respectively; and wherein said polymer has a weight average molecular weight within the range of from 10,000 to 40,000. The method according to claim 3 wherein said polymer has a mole ratio of acrylic acid to acrylamide to acrylamidomethylsulphonic acid of 50:30:20. The method according to any of claims 1 to 4, wherein said product polymer consists of an organic phosphonate of [hexamethylene bis(nitrilodimethylene)]-tetraphosphonic acid or salts thereof, said N-substituted acrylamide polymer, a caustic capable of neutralizing to pH of 6-7, and water. The method according to any of claims 1 to 4, wherein said product polymer consists of an organic phosphonate of 2-phosphonobutane-1,2,4-tricarboxylic acid, said N-substituted acrylamide polymer, a caustic capable of neutralizing to pH of 6-7, and water. The method according to any of claims 1 to 6, wherein said product polymer is added to said feedstream in an amount between 0.3 and 20 ppm polymer actives. The method according to any of claims 1 to 7 wherein the pH of the feedstream is not greater than 6.5. The method according to any of claims 1 to 8 wherein said product polymer is added to the feedstream in a ratio of product polymer to iron of about 0.5:1 or greater, preferably about 0.6:1 or greater.

Inventors: SODERQUIST CYNTHIA A, ZEIHER E H KELLE, SODERQUIST, CYNTHIA A., ZEIHER, E.H. KELLE
Applicants: NALCO CHEMICAL CO, NALCO CHEMICAL COMPANY
Application year: 1994
Main classification: C02F5
IPC codes: B01D65, B01D61, C02F5, C02F1